Quick Answer
Veradermics, Inc reported Cash and Equivalents of $21.77 million for fiscal year 2025.
Veradermics, Inc Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $21.77M | -59.0% |
| 2024 | $53.08M | — |
- Veradermics, Inc showed a decrease of -59.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2024–2025 period, Veradermics, Inc’s cash and equivalents has declined by 59.0% (from $53.08 million to $21.77 million).
- The most recent figure is from Veradermics, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: